https://www.biospace.com/cns-pharmaceuticals-announces-adaptive-trial-design-for-berubicin-phase-2-clinical-trial-to-be-submitted-for-fda-review
CNS Pharmaceuticals Announces Adaptive Trial Design For Berubicin Phase 2 Clinical Trial To Be...
Nov 10, 2020 - CNS to Discuss Potentially Pivotal Phase 2 Trial for Berubicin in Webcast on November 12th; Adaptive Trial Design May Open Opportunity for Expedited Pathway...
adaptive trial designto becnspharmaceuticalsannounces
https://www.pharmafocusasia.com/clinical-trials/adaptive-trial-design
Adaptive Trial Design for Clinical Trials | PharmaFocus Asia
Learn about adaptive trial design and its role in healthcare advertising opportunities, targeted healthcare advertising, medical device advancements, and...
adaptive trial designfor clinical trialsasia